Robert "Bob" Giuffra, co-chair of prominent Am Law 100 firm Sullivan & Cromwell, became known as a legal adviser to the president once he took on Donald Trump's New York criminal appeal ...

Robert "Bob" Giuffra, co-chair of prominent Am Law 100 firm Sullivan & Cromwell, became known as a legal adviser to the president once he took on Donald Trump's New York criminal appeal ...

Sullivan & Cromwell is beefing up its practice that defends corporations against shareholder activist attacks. The prestigious New York-based law firm said Wednesday that it is set to hire two ...

Lawrence Elbaum and Patrick Gadson, two co-chairs of the shareholder activism practice at Vinson & Elkins, have left to join Sullivan & Cromwell. “Lawrence and Patrick are two of the country’s ...

Sullivan & Cromwell is a leader in international M&A and antitrust matters. In 2018, the law firm’s 13 offices advised clients on 173 M&A deals worth more than $450 billion. During the 2008 ...

Sullivan & Cromwell is beefing up its practice that defends corporations against shareholder activist attacks. The prestigious New York-based law firm is set to hire two top activism defense ...

Matthew Herper covers medical innovation — both its promise and its perils. A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap ...

Houle most recently worked at Sullivan & Cromwell as a partner, where she held roles including special counsel to the firm's litigation group and special counsel to the national security practice.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...